Showing results (1101-1110 of 1,111) with videos related to

Sort By:
Pageof 112
Human Fertility (Cambridge, England)|September 30, 2005
When things become what you call themJohan T Hazekamp
Human Fertility (Cambridge, England)|November 6, 2023
Assisted reproductive technology and imprinting errors: analyzing underlying mechanisms from epigenetic regulationGaochen Zhang, Yiting Mao, Yu Zhang, et al.
Human Fertility (Cambridge, England)|January 11, 2023
Application of artificial neural networks in reproductive medicineGuanghui Yuan, Bohan Lv, Cuifang Hao
Human Fertility (Cambridge, England)|April 15, 2026
Enablers and barriers to assisted reproduction and fertility services for Pacific peoples in Aotearoa New Zealand: a qualitative studyCameron D Young, Rebekah G Kennedy, Rhonda M Shaw, et al.
Human Fertility (Cambridge, England)|April 15, 2026
The global evaluation of the effects of antioxidants on seminal outcomes in infertile men: a systematic review and meta-analysisQinyan Xu, Zhongying Wan, Zhiyuan Xiong, et al.
Human Fertility (Cambridge, England)|April 10, 2026
Advancing embryo transfer precision: narrative synthesis of four-dimensional versus two-dimensional ultrasound guidance in IVFAisha Anwar, Vindya Pathiraja, Tharanga Mudalige, et al.
Human Fertility (Cambridge, England)|March 31, 2026
Does cervical mucus removal before embryo transfer have an effect on cycle outcome in women undergoing ICSI?: A randomised controlled trialMuserref Banu Yilmaz, Belgin Devranoglu, Habibe Ayvacı Tasan, et al.
Human Fertility (Cambridge, England)|August 13, 2026
Determinants of total fertility rate between 2011 and 2023 in Türkiye: a comparative panel analysisNilüfer Pekin Alakoç
Human Fertility (Cambridge, England)|September 10, 2026
Autophagy activation in granulosa cells as a mechanism of astaxanthin action: evidence from a pilot randomised trial in PMOS-associated infertilityArezoo Maleki-Hajiagha, Ashraf Aleyasin, Fardin Amidi
Human Fertility (Cambridge, England)|October 5, 2026
Is there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?Raashi Shah, Jennifer Barcroft, Hannan Al-Lamee, et al.
Pageof 112